Stock Price Quote

FDC LTD.

NSE : FDCBSE : 531599ISIN CODE : INE258B01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE448.30-3.55 (-0.79 %)
PREV CLOSE ( ) 451.85
OPEN PRICE ( ) 451.00
BID PRICE (QTY) 448.65 (2)
OFFER PRICE (QTY) 449.35 (1)
VOLUME 6061
TODAY'S LOW / HIGH ( )444.60 453.80
52 WK LOW / HIGH ( )257.75 487.5
NSE448.60-3.4 (-0.75 %)
PREV CLOSE( ) 452.00
OPEN PRICE ( ) 451.95
BID PRICE (QTY) 448.60 (11)
OFFER PRICE (QTY) 448.80 (27)
VOLUME 96016
TODAY'S LOW / HIGH( ) 444.10 453.95
52 WK LOW / HIGH ( )262.05 487.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 23-09 1940
Management Info
Uday Kumar Gurkar - Chairman Mohan A Chandavarkar - Managing Director
Registered Office

Address B-8,Midc Industrial Area,Waluj Dist,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431136

Phone 0240- 2554407 / 2554967 / 2554299

Email waluj@fdcindia.com

Website www.fdcindia.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

03Apr FDC informs about disclosure
FDC has informed that the exchange has received the disclosure under Reg..
09Jan FDC informs about certificate
FDC has informed that it enclosed the certificate issued by the Registra..
16Dec FDC informs about details of loss of c
Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, FDC h..
16Nov FDC submits investor presentation
FDC has informed that it enclosed Investor Presentation- Quarter 2 and Y..
15Sep FDC informs about post offer public an
FDC has informed that in reference to the Buy Back Offer of Equity Share..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit783.762009.65
Gross Profit 963.32 2656.9
Operating Profit 1072.323084.87
Net Sales 4522.1517770.32

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)775.18
Abbott India (BSE)
peergroup  26150.00 (0.36%)
M.Cap ( in Cr)55594.55
Solara Active Pharma (BSE)
peergroup  548.65 (15.72%)
M.Cap ( in Cr)1886.74
Windlas Biotech (BSE)
peergroup  542.15 (4.48%)
M.Cap ( in Cr)1105.44
Concord Biotech (BSE)
peergroup  1595.05 (1.04%)
M.Cap ( in Cr)16743.30

Shareholding Pattern

PROMOTERS 69.66%
MUTUAL FUNDS/UTI 6.69%
NON-INSTITUTION 20.76%
FI/BANKS/INSURANCE 0.07%
GOVERNMENT 0%
FII 0%

About FDC Ltd.

FDC Ltd. was incorporated in the year 1940. Its today's share price is 448.3. Its current market capitalisation stands at Rs 7338.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 18324.91 Cr and Total Income of Rs.18323.26 Cr. The company's management includes Vijay Nautamlal Bhatt, Vijay Maniar, Mahesh Bijlani, Usha Athreya Chandrasekhar, Melarkode Ganesan Parameswaran, Swati S Mayekar, Nomita R Chandavarkar, Ameya A Chandavarkar, Ashok A Chandavarkar, Nandan M Chandavarkar, Mohan A Chandavarkar, Uday Kumar Gurkar, Varsharani Katre.

It is listed on the BSE with a BSE Code of 531599 , NSE with an NSE Symbol of FDC and ISIN of INE258B01022. It's Registered office is at B-8,Midc Industrial Area,Waluj DistChhatrapati Sambhajinagar - (Aurangabad)-431136, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, RSM & Co, SR Batliboi & Associates, SR Batliboi & Co, SR Batliboi & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.